Review
[Medical treatment of osteoporosis in men]
[Article in
Danish]
Affiliations
- PMID: 26324291
Item in Clipboard
Review
[Medical treatment of osteoporosis in men]
[Article in
Danish]
Ugeskr Laeger.
.
Free article
Abstract
One in five men over the age of 50 years will suffer an osteoporotic fracture during their lifetime, and men who sustain fractures have an increased mortality risk compared to women. Three bisphosphonates (alendronate, risedronate and zolendronic acid), denosumab, strontium ranelate and teriparatide are currently approved in Denmark for the treatment of osteoporosis in men. This review summarizes the available therapeutic options.
Similar articles
-
Denosumab: a cost-effective alternative for older men with osteoporosis from a Swedish payer perspective.Bone. 2014 Feb;59:105-13. doi: 10.1016/j.bone.2013.11.002. Epub 2013 Nov 12. Bone. 2014. PMID: 24231131
-
Treatment of primary osteoporosis in men.Clin Interv Aging. 2014 Dec 30;10:105-15. doi: 10.2147/CIA.S44057. eCollection 2015. Clin Interv Aging. 2014. PMID: 25565793 Free PMC article. Review.
-
Indirect comparison of teriparatide, denosumab, and oral bisphosphonates for the prevention of vertebral and nonvertebral fractures in postmenopausal women with osteoporosis.Menopause. 2015 Sep;22(9):1021-5. doi: 10.1097/GME.0000000000000466. Menopause. 2015. PMID: 25944523
-
[Male osteoporosis].Z Rheumatol. 2016 Jun;75(5):459-65. doi: 10.1007/s00393-016-0078-2. Z Rheumatol. 2016. PMID: 27117306 Review. German.
-
Efficacy and safety of pharmacological agents in managing osteoporosis in the old old: review of the evidence.Bone. 2009 May;44(5):744-51. doi: 10.1016/j.bone.2008.12.003. Epub 2008 Dec 16. Bone. 2009. PMID: 19130909 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
